Back
Caribou Biosciences Vs. Beam Therapeutics Industry Stock Comparison
Sell
49
CRBU
Caribou Biosciences
Last Price:
2.07
Seasonality Move:
-21.17%
Sell
32
BEAM
Beam Therapeutics
Last Price:
25.66
Seasonality Move:
30.53%
Sell
49
Caribou Biosciences (CRBU)
is a Sell
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $2.06. The Score for CRBU is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRBU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $25.67. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $2.06
The current trend is relatively stagnant and CRBU is experiencing slight buying pressure.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $25.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.
CRBU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.88 | Buy |
| Chaikin Money Flow: | 320594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.92 - 2.18) | Buy |
| Bollinger Bands (100): | (1.69 - 2.97) | Sell |
BEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 51.87 | Buy |
| Chaikin Money Flow: | 83316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.08 - 26.32) | Buy |
| Bollinger Bands (100): | (22.77 - 27.33) | Buy |
CRBU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Sell |
| 20-day SMA: | 2.03 | Buy |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 4.02 | Sell |
| 8-day EMA: | 2.05 | Buy |
| 20-day EMA: | 2.04 | Buy |
| 50-day EMA: | 2.13 | Sell |
| 200-day EMA: | 3.47 | Sell |
BEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.41 | Buy |
| 20-day SMA: | 25.31 | Buy |
| 50-day SMA: | 26.3 | Sell |
| 200-day SMA: | 27.31 | Sell |
| 8-day EMA: | 25.44 | Buy |
| 20-day EMA: | 25.3 | Buy |
| 50-day EMA: | 25.54 | Buy |
| 200-day EMA: | 26.92 | Sell |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.48 per share, and an increase next year of $0.06 per share.
Caribou Biosciences Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Beam Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||